Skip to main content
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED logo

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED — Investor Relations & Filings

Ticker · MVP ISIN · AU000000MVP2 LEI · 9845007EAECAOD1U4493 ASX Manufacturing
Open in API
Filings indexed 908 across all filing types
Latest filing 2021-09-26 Capital/Financing Update
Country AU Australia
Listing ASX MVP

About MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

https://medicaldev.com

Medical Developments International Limited specializes in the development and distribution of emergency pain relief and respiratory products. The company's flagship product is Penthrox, a handheld, self-administered inhaler providing rapid-onset, non-opioid analgesia using methoxyflurane. Penthrox is utilized globally by emergency medical services, hospitals, and for procedural pain in various clinical settings. Additionally, the company manufactures a range of respiratory medical devices, including anti-static spacers and asthma management tools designed to optimize medication delivery. The organization focuses on providing portable, effective solutions for acute pain management and respiratory care, catering to healthcare professionals and patients in emergency, surgical, and primary care environments.

Recent filings

Filing Released Lang Actions
Proposed issue of securities - MVP 5 pages 27.2KB
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding a proposed issue of securities by Medical Developments International Limited. It details the number and type of securities to be issued, the issue price, the proposed issue date, and compliance with ASX listing rules. There is no financial data or report content, only information about the capital raising activity. This fits the definition of a Capital/Financing Update (CAP). The document length is moderate and contains detailed information about the securities issuance, not just a brief notice or a report publication announcement. Therefore, the correct classification is CAP with high confidence.
2021-09-26 English
Annual Report to shareholders 80 pages 10.3MB
Annual Report Classification · 100% confidence The document is titled 'FULL YEAR REPORT 2021' and covers the financial year ended 30 June 2021, indicating it is a comprehensive yearly report. It includes detailed financial results such as net loss, revenue, impairments, expenses, cash flow, and outlook. It also contains management commentary from the CEO and Chair, operational updates, and strategic initiatives. The length is substantial (15,000 characters), and the content includes actual financial data and analysis rather than just an announcement or summary. There is no indication that this is merely an announcement of a report or a certification. The presence of detailed financial performance and management discussion aligns with the definition of an Annual Report (10-K).
2021-09-22 English
Notice of Annual General Meeting/Proxy Form 12 pages 514.0KB
AGM Information Classification · 100% confidence The document is titled 'Notice of Eighteenth Annual General Meeting' and includes detailed information about the date, time, and virtual attendance of the AGM. It outlines the agenda items such as receiving and considering the Financial Report, Directors' Report, and Auditor's Report for the period ended 30 June 2021, adoption of the Remuneration Report, election of directors, and allocation of securities to a non-executive director. The document also provides instructions for shareholders on how to attend, vote, and submit proxies for the meeting. There is no actual financial data or detailed report content included; rather, it is a formal notice inviting shareholders to the AGM and explaining the meeting procedures and agenda. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting, specifically the notice of meeting and related instructions. The document length (15,000 characters) is consistent with a detailed AGM notice rather than a brief announcement or proxy statement. Therefore, the appropriate classification is AGM Information (AGM-R).
2021-09-22 English
Change of Director's Interest Notice 2 pages 157.7KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, dates of transactions, and nature of the interest. The document is a formal notification of insider share transactions by a company director. It does not contain financial statements, earnings data, or management discussion. The document length is 3619 characters, which is relatively short and focused solely on director share dealings. Therefore, this document fits the category of Director's Dealing (DIRS).
2021-09-06 English
Change of Director's Interest Notice 2 pages 155.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's change in shareholding, including the number of shares acquired, disposed, and held before and after the transaction. The document is a formal notification of a director's personal share transactions, specifically an on-market purchase of shares. It does not contain financial statements, management discussion, or other report content. The document length is 3247 characters, which is consistent with a short notice rather than a full report. Therefore, this document fits the definition of 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades).
2021-09-05 English
Change of Director's Interest Notice 2 pages 156.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's acquisition of shares, including the number of shares held before and after the transaction, the date of change, and the nature of the transaction (on-market purchase). This type of document is a report of personal share transactions by company directors and executives, commonly known as insider trades. It is not a financial report, earnings release, or any other type of corporate filing. Therefore, the correct classification is Director's Dealing (DIRS). The document length is 3215 characters, which is consistent with a detailed insider trading notice rather than a full report or announcement of a report.
2021-08-29 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.